scholarly journals Allo-limbal transplantation in patients with limbal stem cell deficiency

1999 ◽  
Vol 83 (12) ◽  
pp. 1409-1409 ◽  
Author(s):  
A. L YOUNG ◽  
A. T S LEUNG ◽  
D. S C LAM; ◽  
H. S DUA ◽  
A. AZUARA-BLANCO ◽  
...  
2021 ◽  
Author(s):  
Christiane Kesper ◽  
Anja Viestenz ◽  
Thomas Hammer ◽  
Joana Heinzelmann ◽  
Sabine Foja ◽  
...  

Abstract PurposeLimbal stem cell deficiency (LSCD) is a rare but extremely relevant disease of the eye. LSCD patients often require a variety of surgical procedures, including keratoplasty in some cases. However, the outcome of these surgeries, including opacification and revascularization, is often frustrating due to LSCD relapse.MethodsWe developed a new surgical technique for the treatment of LSCD in which partial allogenic limbal transplantation (PALT) is carried out as part of penetrating keratoplasty (PK). After the PK, 1-8 slices from the limbal tissue of the donor graft are prepared and placed under the double running sutures attaching the corneal graft. This procedure was performed on 14 patients with LSCD, caused by severe ocular burn in 5 cases and by infection in 9. Between one and eight limbal transplants were used depending on the extension of the LSCD. ResultsAll 14 patients showed stable or increased visual acuity after the PALT surgery compared to their preoperative visual acuity. All of the grafts were integrated into the superficial corneal layers without progression of corneal vascularization beyond the limbal grafts. The median follow-up period was 12 months on average.ConclusionThe PALT method seems to be a promising surgical procedure for the treatment of patients with LSCD. It can be properly carried out in the context of keratoplasty and does not require a separate donor tissue. The PALT grafts may offer the possibility of constructing a new limbal region, resulting in stable or even increased visual acuity and the absence of corneal vascularization.


2018 ◽  
Vol 27 (2) ◽  
pp. 264-274 ◽  
Author(s):  
Marie-Rose Rovere ◽  
Patricia Rousselle ◽  
Marek Haftek ◽  
Bruce Charleux ◽  
Viridiana Kocaba ◽  
...  

Total bilateral limbal stem cell deficiency leading to loss of corneal clarity, potential vision loss, pain, photophobia, and keratoplasty failure cannot be treated by autologous limbal transplantation, and allogeneic limbal transplantation requires subsequent immunosuppressive treatment. Cultured autologous oral mucosal epithelial cells have been shown to be safe and effective alternatives. These cells can be transplanted on supports or without support after detachment from the culture dishes. Dispase, known for epidermal sheet detachment, is reported as not usable for oral mucosa. The objective was to find an optimized detachment method providing a sufficiently resistant and adhesive cultured oral mucosal epithelium (COME), which can be grafted without sutures. Enzymatic treatments (dispase or collagenase at different concentrations) were compared to enzyme-free mechanical detachment. Histological immunofluorescence (IF) and Western blotting (WB) were used to examine the impact on adhesion markers (laminin-332, β1-integrin, and type VII collagen) and junctional markers (E-cadherin, P-cadherin). Finally, the COME ability to adhere to the cornea and produce a differentiated epithelium 15 d after grafting onto an ex vivo porcine stroma model were investigated by histology, IF, and transmission electron microscopy. Collagenase at 0.5 mg/mL and dispase at 5 mg/mL were selected for comparative study on adhesive expression marker by IF and WB showed that levels of basement membrane proteins and cell–cell and cell–matrix junction proteins were not significantly different between the 3 detachment methods. Collagenase 0.5 mg/mL was selected for the next step validation because of the better reproducibility, 100% success (vs. 33% with dispase 5 mg/mL). Grafted onto porcine de-epithelialized corneal stroma, collagenase 0.5 mg/mL detached COME were found to adhere, stratify, and continue to ensure renewal of the epithelium. For COME, collagenase 0.5 mg/mL enzymatic detachment was selected and validated on its resistance and adhesive marker expression as well as their anchorage onto our new ex vivo de-epithelialized stroma model.


Author(s):  
Pinnita Prabhasawat ◽  
Chareenun Chirapapaisan ◽  
Panotsom Ngowyutagon ◽  
Pattama Ekpo ◽  
Wimolwan Tangpagasit ◽  
...  

2011 ◽  
Vol 43 (5) ◽  
pp. 433-442 ◽  
Author(s):  
Chuan Gu ◽  
Tao Ni ◽  
Erol E. Verter ◽  
Robert W. Redmond ◽  
Irene E. Kochevar ◽  
...  

2009 ◽  
Vol 24 (3) ◽  
pp. 139-148 ◽  
Author(s):  
Pauline Lim ◽  
Thomas A. Fuchsluger ◽  
Ula V. Jurkunas

Sign in / Sign up

Export Citation Format

Share Document